BIO-B

BIO-RAD LABORATORIES, INC.

BIO-B · CIK 12208 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$2.6B
20182025
Net Income$0.8B
20182025
Operating CF$0.5B
20182025
Free Cash Flow$0.4B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$2.6B$2.6B$2.7B$2.8B$2.9B$2.5B$2.3B$2.3B
Cost of Revenue$1.2B$1.2B$1.2B$1.2B$1.3B$1.1B$1.1B$1.1B
Gross Profit$1.3B$0.3B$0.4B$0.4B$0.4B$0.5B$0.3B$0.3B
R&D Expense$0.3B$0.3B$0.2B$0.3B$0.3B$0.2B$0.2B$0.2B
SG&A Expense$0.8B$0.8B$0.8B$0.8B$0.9B$0.8B$0.8B$0.8B
Operating Income$0.0B$0.3B$0.3B$0.5B$0.5B$0.4B$0.2B$-0.1B
Net Income$0.8B$-0.7B$0.3B$0.8B$-1.6B$0.8B$0.6B$-0.8B
EPS (Basic)$27.87$-25.57$12.15$27.89$-52.59$28.13$18.50$-27.73
EPS (Diluted)$27.85$-25.57$12.14$27.78$-52.59$27.81$18.31$-27.73

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$10.6B$9.4B$12.3B$13.5B$17.8B$13.0B$8.0B$5.6B
Current Assets$2.9B$3.0B$3.0B$3.2B$2.0B$2.1B$2.2B$2.0B
Cash & Equivalents$0.5B$0.5B$0.4B$0.4B$0.5B$0.7B$0.7B$0.4B
Total Liabilities$3.1B$2.8B$3.6B$3.9B$4.1B$3.1B$2.3B$1.6B
Current Liabilities$0.5B$0.5B$0.5B$0.6B$0.7B$0.6B$0.9B$0.5B
Stockholders' Equity$7.5B$6.6B$8.7B$9.6B$13.7B$9.9B$5.8B$4.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.5B$0.5B$0.4B$0.2B$0.7B$0.6B$0.5B$0.3B
Investing Cash Flow$-0.2B$-0.2B$0.0B$-1.2B$-0.8B$-0.1B$-0.2B$-0.2B
Capital Expenditures$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B
Financing Cash Flow$-0.3B$-0.2B$-0.4B$1.0B$-0.1B$-0.5B$-0.0B$-0.0B
← Companies